Introduction
============

Obesity is still a major health problem with an increased incidence [@R07-2018-0098-0023] . It is associated with other cardiovascular risk factors and increased risk of all-cause mortality [@R07-2018-0098-0039] . In the treatment of obesity, physical exercise is an intensely investigated and essential part. Various reviews state beneficial effects of traditional moderate-intensity continuous training (MICT) and short-term high-intensive training (HIT) on cardiovascular risk factors in obesity [@R07-2018-0098-0019] [@R07-2018-0098-0029] . The success of these training programs is based on the optimal exercise intensity. In this context, there are various commonly used methods of estimating exercise intensities: oxygen uptake reserve (VO ~2R~ ), heart rate reserve (HRR), percent of the maximum heart rate (%HR ~max~ ) and percent of the maximal oxygen uptake (%VO ~2max~ ) [@R07-2018-0098-0014] . All of these methods depend on the adequate motivation of the investigated subject, which seems problematic especially for untrained and overweight persons.

In light of this, research focuses on the detection of the anaerobic threshold (ANT) and is intensely investigated. The ANT may typically be determined through use of graded exercise tests by analysis of blood lactate concentration [@R07-2018-0098-0012] . When defining the areas of training and determining individual intensity ranges, the application of graded exercise tests and analysis of blood lactate concentration is to be preferred to the HF ~max~ and VO ~2max~ procedures [@R07-2018-0098-0012] [@R07-2018-0098-0032] . The gold standard method to detect the ANT is the determination of the maximal lactate steady state (MLSS) [@R07-2018-0098-0012] . The MLSS is defined as the highest constant workload that still leads to an equilibrium between lactate production and lactate elimination [@R07-2018-0098-0006] [@R07-2018-0098-0012] . The determination of the MLSS requires several submaximal exercise tests and the analysis of blood lactate concentration on different days [@R07-2018-0098-0006] . However, this approach entails the use of an invasive method that requires high organizational effort and time.

In the last 3 decades, heart rate variability (HRV) has frequently been investigated during physical activity [@R07-2018-0098-0002] in relation to training adaptations [@R07-2018-0098-0026] and for monitoring athletic training status [@R07-2018-0098-0005] . In this context, various studies investigated the relationship between ANT and HRV. Several investigations demonstrated high agreements between different lactate thresholds (LT) with so-called HRV thresholds (HRVt): Karapetian et al. [@R07-2018-0098-0018] demonstrated high correlations of LT and HRVt in 28 subjects with a wide range of aerobic capacities and fitness levels on a bicycle ergometer. Di Michele et al. [@R07-2018-0098-0021] compared LT and HRV in 14 high-level swimmers and reported high agreements of HRVt and LT. To our knowledge, only one study group so far has focused on the relationship between HRV and the MLSS: Flöter et al. [@R07-2018-0098-0013] demonstrated a high agreement between HRVt and the MLSS in well-trained athletes.

However, several cross-sectional studies reported a reduction of HRV in overweight and obese individuals compared to normal-weight persons [@R07-2018-0098-0022] [@R07-2018-0098-0028] [@R07-2018-0098-0040] . It is assumed that the reduction of HRV is mainly caused by depression of cardiac parasympathetic activity [@R07-2018-0098-0022] [@R07-2018-0098-0025] . Recent evidence furthermore suggests that cardiac autonomic regulation may play an important role in exercise tolerance [@R07-2018-0098-0004] . Therefore, it can be assumed that body fat influences parasympathetic regulation and, as a consequence, affects physical performance. To the best of our knowledge, there are no studies that compared HRV and the MLSS in overweight and obese subjects. Consequently, the aim of this study was to assess if the MLSS may be detected by HRV in overweight and obese individuals. The hypothesis of this study was that the MLSS could be detected by HRV in overweight and obese individuals.

Methods
=======

Participants
------------

Participants were recruited within the Hamburg area in Germany via word of mouth, flyers, social media, and advertisements. Participants were included in the study if they were (1) aged between 18 to 60 years; (2) BMI between 25 to 40 kg·m ^−2^ ; and (3) abdominal girth: male\>102 cm, female\>96 cm. The sample size was divided into two groups: overweight participants (OW) with a BMI between 25 to 29.9 kg·m ^−2^ and obese participants (OB) with a BMI between 29.9 to 40 kg·m ^−2^ . Participants were excluded if they suffered from systemic disorders, such as diabetes, heart disease, metabolic diseases, severe orthopedic disorders, acute or chronic infections, or mental disorders. All participants provided written informed consent. The study was conducted in accordance with the ethical standards required by the journal [@R07-2018-0098-0016] and was approved by the Ethics Committee of the Hamburg Medical Council (PV3592).

Testing procedure
-----------------

The investigation was performed at the Institute of Human Movement Science, University of Hamburg. The study protocol included 1 incremental exercise test and 2 to 3 constant submaximal load tests on a cycle ergometer within a period of 4 weeks. The bicycle ergometer was chosen due to the minimal electrocardiogram (ECG) artefacts during exercise. The incremental test was performed to measure HRV, to calculate the load for the first constant-load test, and to assess the level of VO ~2peak~ . The constant-load tests were conducted to determine the MLSS. Before testing, participants were familiarized with the experimental procedure. Intensive physical activity and consuming alcohol and caffeine within 24 h were prohibited. All tests were conducted at the same time of day. Intervals between tests were at least 2 days and at most 7 days. All tests were conducted on a bicycle ergometer whose rotational speed was independent and that slowed down electromagnetically (Lode Excalibur Sport 1000 W, Lode BV Medical Technology, Groningen, Netherlands). In all tests, the participants were required to ride with a pedal rotation of 60--90 rotations·min  ^−1 ^ . Each test started with a warm-up period of 5 min at 25 W and ended with an active recovery period of 5 min at 25 W.

Incremental exercise test
-------------------------

Work load was first applied at an intensity of 25 W and was increased by 8.3 W·min ^−1^ , resulting in 25 W every 3 min up to volitional exhaustion [@R07-2018-0098-0003] . Capillary blood samples were taken in the beginning, every 3 min, and in the first, third and fifth post-exercise minute. During the tests, continuous electrocardiograms (ECGs) were taken to calculate the HRV.

Constant-load tests
-------------------

Each constant-load test included a warm-up period and a 30-min workload exercise bout. The initial workload for the first constant-load test based on the threshold determination according to Stegmann [@R07-2018-0098-0031] measured during the incremental exercise test. In the beginning and every 3 min within the last 20 min capillary blood samples were taken. If a steady state of the blood lactate concentration (BLC) was achieved or BLC decreased during constant workload, the following constant load was increased by 3--10% of the initial value. If blood lactate concentration increased or the test could not be completed due to exhaustion, the subsequent constant workload was conducted at a reduced workload intensity [@R07-2018-0098-0006] .

Blood lactate analysis
----------------------

Capillary blood samples (25 µl) were taken from the earlobe and were automatically analyzed. The lactate concentration was calculated by using Ebio plus (C line, EKF-Diagnostik, Germany) [@R07-2018-0098-0013] .

Gas measurements
----------------

The exhaled gases for the determination of the VO ~2peak~ were measured breath by breath (Oxycon Pro; Jaeger, Bunnik, Netherlands). VO ~2peak~ values were calculated as the mean of the two highest 30-s records.

Anthropometry
-------------

Height, weight, and abdominal girth were measured directly before testing. Body fat was determined with the help of a caliper [@R07-2018-0098-0024] .

Maximal lactate steady state
----------------------------

MLSS represents the highest constant workload that still leads to equilibrium between lactate production and lactate elimination [@R07-2018-0098-0012] . More precisely, the MLSS is defined as the highest workload during which blood lactate concentration (BLC) increases by no more than 1.0 mmol·l ^−1^ during the final 20 min of a 30 min constant-load test [@R07-2018-0098-0006] [@R07-2018-0098-0017] . The gold standard for the determination of the MLSS is performing several constant load trials of at least 30 min duration on different days at various exercise intensities [@R07-2018-0098-0012] .

Heart rate variability analysis
-------------------------------

During the incremental exercise test, R waves were automatically detected from a 12-channel ECG (vicardio, GETEMED, Teltow, Germany) (sample rate: 1000 Hz). The raw set of data for the intervals between successive heartbeats (RR intervals) was visually monitored and cleared of artefacts before being imported into specifically developed software (vicardio). The data was filtered by a digital 5th-order Butterworth low-pass filter (8 Hz). Only RR intervals with a deviation of less than 75% from the preceding or following RR interval were accepted. To illustrate the complete variability of the heart rate, the standard deviation of RR intervals (SDNN) was calculated. Furthermore, we conducted a quantitative analysis of the Poincaré plot and calculated the standard deviation of the transverse axis (SD1) and of the longitudinal axis (SD2) [@R07-2018-0098-0036] [@R07-2018-0098-0037] .

Heart rate variability thresholds
---------------------------------

Each HRV parameter was separately analyzed in the range between 50% and 80% of the maximum power in W (P ~max~ ), because the ANT is expected to be in this range [@R07-2018-0098-0013] [@R07-2018-0098-0018] . The last 2 min of each exercise stage were subdivided into segments of 50 RR intervals. The moving average was calculated and displayed on a curve [@R07-2018-0098-0013] . For the parameter SD1, the minimum value of the curve was defined as the HRVt (HRVt ~SD1~ ). For the parameter SD2 and SDNN the onset of the plateau phase [@R07-2018-0098-0013] was defined as the HRVt (HRVt ~SD2~ and HRVt ~SDNN~ ). The corresponding power (W) value was identified for further use in the statistical analysis.

Statistical analysis
--------------------

Data are expressed as mean with standard deviation and 95% confidence interval (CI). The power output at the MLSS and HRVt are expressed as absolute values (W) and in relation to maximal power (%P ~max~ ). Differences of power output between the MLSS and HRVt are expressed as a percentage. The Kolmogorov-Smirnov test was used to test for normal distribution. Mean differences between OW and OS were tested using the Student's *t* -test and Mann-Whitney test. Mean values of power output (W) at the MLSS and at each HRVt were compared by Pearson\'s and Spearman\'s correlation coefficients. Additionally, Bland-Altman plots were used to test relationships between the MLSS and HRVt [@R07-2018-0098-0010] . Statistical significance was set at p\<0.05. Statistical analysis was performed using SPSS ^©^ 21.0.

Results
=======

For 2 participants, HRVt could not be determined because the quality of the ECG was insufficient. One participant discontinued the trial without giving a reason and another subject was not able to perform the endurance tests to determine the MLSS. Characteristics of the remaining study participants (n=28) are shown in [Table 1](#TB07-2018-0098-0001){ref-type="table"} . Performance characteristics are listed in [Table 2](#TB07-2018-0098-0002){ref-type="table"} . Correlation coefficients between power output at the MLSS and power output at the HRVt parameters are shown in [Table 3](#TB07-2018-0098-0003){ref-type="table"} . There were no significant differences for mean power output at any HRVt parameter and the MLSS between groups ( [Table 3](#TB07-2018-0098-0003){ref-type="table"} ). HRVt and the MLSS could be detected between 62.6 to 77.6% of %P ~max~ , with no significant differences between groups ( [Table 4](#TB07-2018-0098-0004){ref-type="table"} ). There were no statistically significant differences between groups for the differences of power output between the MLSS and HRVt ( [Table 4](#TB07-2018-0098-0004){ref-type="table"} ). For OW as well as OB participants, Bland-Altman plots demonstrate moderate to good agreements for all tests with the MLSS ( [Fig. 1](#FI07-2018-0098-0001){ref-type="fig"} ). The lowest discrepancy was observed in HRVt ~SDNN~ with 16.0 W, whereas the largest discrepancy demonstrated HRVt ~SD2~ with 19.8 W. The smallest limit of agreement demonstrated HRVt ~SD1~ (29.0 to−65.9 W). The largest limit of agreement reveals HRVt ~SDNN~ (39.5 to−71.5). Overall, Bland-Altman plots demonstrated that power at HRVt did not depend on the amount of power output at the MLSS ( [Fig. 1](#FI07-2018-0098-0001){ref-type="fig"} [2](#FI07-2018-0098-0002){ref-type="fig"} [3](#FI07-2018-0098-0003){ref-type="fig"} ).
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###### 

**Table 1** Characteristics of study participants.

  Characteristic                        All (n=28)   Overweight subjects (n=14)   Obese subjects (n=14)   p-value
  ------------------------------------- ------------ ---------------------------- ----------------------- ---------
  Age (years)                           38.5±13.1    38.9±12.7                    38.1±13.9               0.877
  Height (cm)                           176.1±8.7    176.6±5.8                    176.5±11.0              0.766
  Weight (kg)                           96.4±16.7    86.1±7.9                     106.6±17.0              \<0.000
  Body mass index (kg·m ^−2^ )          30.9±4.4     27.4±1.6                     34.4±3.4                \<0.000
  Body fat (%)                          29.2±4.3     27.8±4.5                     30.6±3.8                0.088
  Abdominal girth (cm)                  107.8±10.9   100.1±6.7                    115.5±8.6               \<0.000
  Waist to hip ratio                    0.9±0.09     0.86±0.1                     0.93±0.07               0.048
  VO ~2peak~ (ml·kg ^−1^ ·min ^−1^ )    31.5±7.6     34.2±8.3                     29.2±5.6                0.106
  Absolute maximum power (W)            193.8±32.8   199.6±30.9                   188.9±34.8              0.439
  Relative maximum power (W·kg ^−1^ )   2.1±0.4      2.2±0.4                      1.9±0.3                 0.044
  Absolute power at MLSS (W)            126.6±30.7   125.4±30.7                   127.3±30.0              0.439
  Relative power at MLSS (W·kg ^−1^ )   1.3±0.4      1.5±0.4                      1.2±0.3                 0.089

Data are reported as mean and standard deviation (±); Abbreviations: MLSS=maximal lactate steady state, W=watt.

###### 

**Table 2** Group differences for performance characteristics.

                                                Mean difference   \[95% CI\]        p-value
  --------------------------------------------- ----------------- ----------------- ---------
  Relative VO ~2peak~ (ml·kg ^−1^ ·min ^−1^ )   5.0               \[−1.2--11.3\]    0.106
  Absolute maximum power (W)                    10.7              \[−13.6--38.8\]   0.439
  Relative maximum power (W·kg ^−1^ )           0.3               \[0.0--0.63\]     0.044
  Absolute power at MLSS (W)                    1.9               \[−26.8--23.0\]   0.877
  Relative power at MLSS (W·kg ^−1^ )           0.3               \[−0.43--0.56\]   0.089

Data are reported as mean and 95% confidence interval \[CI\]; Abbreviations: MLSS=maximal lactate steady state, W=watt.

###### 

**Table 3** Absolute power output and correlations to MLSS of study participants.

                All          Overweight *n* =13   Obese *n* =11                                               
  ------------- ------------ -------------------- --------------- ------------- ------------ ---------------- -------
  MLSS          126.6±30.7                        125.4±30.7                    127.3±30.0                    0.877
  HRVt ~SD1~    144.8±31.9   0.69 **\*\* **       143.9±37.0      0.66 **\***   145.9±26.6   0.76 **\*\* **   0.879
  HRVt ~SD2~    146.1±30.1   0.60 **\***          146.5±31.5      0.66 **\***   145.5±28.4   0.56             0.933
  HRVt ~SDNN~   142.3±31.3   0.56 **\***          145.4±34.4      0.56 **\***   138.6±28.4   0.59             0.609

Data are reported as mean and standard deviation (±); \*  Denotes a statistical significance for correlation analysis; \*\* Denotes a statistically high significance for correlation analysis; Abbreviations: HRV=heart rate variability, MLSS=maximal lactate steady state, SD=standard deviation, SDNN=standard deviation of all normal RR intervals.

###### 

**Table 4** Power output in relation to maximal power and differences of HRVt to MLSS of study participants.

                All         Overweight *n* =13   Obese *n* =11                          
  ------------- ----------- -------------------- --------------- ----------- ---------- -----------
  MLSS          64.9±7.4                         66.8±7.1                    62.6±7.4   
  HRVt ~SD1~    74.5±8.4    19.9±16              75.9±10.5       22.4±15.6   72.9±4.8   16.8±16.6
  HRVt ~SD2~    75.3±9.5    22.6±15.2            77.6±10.6       22.4±17.0   72.6±9.0   22.9±13.7
  HRVt ~SDNN~   73.2±10.2   21.2±16.6            76.6±10.6       24.2±18.4   69.2±8.4   17.7±14.2

Data are reported as mean and standard deviation (±); Abbreviations: HRV=heart rate variability, MLSS=maximal lactate steady state, SD=standard deviation, SDNN=standard deviation of all normal RR intervals..

Discussion
==========

The present study was designed to assess if the MLSS could be detected by HRV in overweight and obese individuals. The results yielded a moderate to strong agreement between the MLSS and HRVt in obese and overweight persons. However, mean differences between the power at the MLSS and the power at all HRVt were relatively large (−16.0 to−19.8 W) ( [Fig. 1](#FI07-2018-0098-0001){ref-type="fig"} [2](#FI07-2018-0098-0002){ref-type="fig"} [3](#FI07-2018-0098-0003){ref-type="fig"} ). Moreover, all HRVt overestimated the MLSS by a substantial amount ( [Table 3](#TB07-2018-0098-0003){ref-type="table"} and [4](#TB07-2018-0098-0004){ref-type="table"} ). In accordance with other studies, HRVt were detected at intensities over 60%P ~max~ [@R07-2018-0098-0001] [@R07-2018-0098-0011] [@R07-2018-0098-0013] . This seems plausible because the vagal tone is reduced within this zone and several studies demonstrated a relation between vagal withdrawal and HRVt [@R07-2018-0098-0009] [@R07-2018-0098-0011] [@R07-2018-0098-0030] [@R07-2018-0098-0037] . Only a few studies investigated HRVt in obese or overweight individuals, and these focused solely on comparisons with ventilatory thresholds (VTs). Shibata et al. \[44\] demonstrated a significant positive correlation (r=0.74) between HR at HRVt and VT in obese women. Vasconcellos et al. [@R07-2018-0098-0038] investigated adolescent boys and reported high correlations between HRVt and VT (r=0.8--r=0.9). Bland-Altman plots demonstrated only small discrepancies in oxygen consumption between HRVt and VT (V0 ~2~ : −3.94 ml·kg ^−1^ ·min ^−1^ ), and the mean difference of power output between HRVt and VT was only 2.8 W [@R07-2018-0098-0038] . In contrast to our results, in both studies HRVt underestimated VT [@R07-2018-0098-0030] [@R07-2018-0098-0038] . Quinart et al. [@R07-2018-0098-0027] investigated twenty adolescents and measured HRVt as well as 2 different VTs (VT1, VT2) during incremental exercise test on a cycle ergometer. The authors demonstrated a high correlation (r=0.93) between the VT2 and HRVt and a small difference in power output at HRVt and VT2 (3.2 W). In line with our findings, HRVt overestimated VT2. The VT2 is characterized by respiratory compensation of load-induced metabolic acidosis and corresponds with exceeding the MLSS [@R07-2018-0098-0007] . This fact could explain the agreement between both investigations. Overall, the above-mentioned studies demonstrated higher correlations compared to our investigation. However, comparisons between the MLSS and VT seem problematic because both concepts reflect similar but different pathophysiological conditions.

Various studies investigated the relationship between different LT and HRVt in normal-weight subjects [@R07-2018-0098-0018] [@R07-2018-0098-0021] . However, only one study group compared HRVt with the MLSS. Flöter et al. [@R07-2018-0098-0013] demonstrated only slight discrepancies (0.4--5.2 W) and high correlations (r=0.80--r=0.89) between the power at the MLSS and the power at HRVt on a cycle ergometer in healthy trained adults. These results are in contrast to the findings we presented here for overweight and obese subjects. The OB and OW demonstrated relatively large discrepancies (−16.0 to−19.8 W) ( [Fig. 1--4](#FI07-2018-0098-0001){ref-type="fig"} ) and only moderate correlations (r=0.56--r=0.76) ( [Table 3](#TB07-2018-0098-0003){ref-type="table"} ). Both investigations were conducted by the same study group and the test protocols were nearly identical. Hence, an influence of body fat during incremental exercise can be considered. Various studies demonstrated a greater vagal withdrawal and increased sympathetic activation compared to normal-weight individuals during rest conditions [@R07-2018-0098-0022] [@R07-2018-0098-0028] [@R07-2018-0098-0040] . It can be assumed that this disturbance of the autonomic nervous system (ANS) is also present during exercise. This disturbance could explain the relatively large discrepancies of the OB and OW participants. Interestingly, all HRVt were detected at higher intensities (69.2--77.6%P ~max~ ) compared to the MLSS (62.6--66.8%P ~max~ ) ( [Table 4](#TB07-2018-0098-0004){ref-type="table"} ). As a consequence, all HRVt overestimated the MLSS by a substantial amount (−16.8 to −22.9 W) ( [Table 4](#TB07-2018-0098-0004){ref-type="table"} ). This was unexpected because various studies demonstrated a maximal vagal withdrawal and an increase of the sympathetic activation close to the LT [@R07-2018-0098-0018] [@R07-2018-0098-0021] . Therefore, our results suggest a delayed vagal withdrawal and a delayed increase of the sympathetic activation during incremental exercise in obese and overweight persons.

Because HRV represents different parts of the ANS, we analyzed various HRV parameters. The primarily vagal-modulated parameter HRVt ~SD1~ [@R07-2018-0098-0015] [@R07-2018-0098-0035] revealed for all subjects and OB higher correlations (r=0.69--r=0.76) and lower differences (16.8--22.4%) compared to the parameter HRVt ~SD2~ (r=0.56--r=0.66; 22.6--22.9%) ( [Table 3](#TB07-2018-0098-0003){ref-type="table"} ), which is vagally as well as sympathetically influenced [@R07-2018-0098-0037] . This is in contrast to Flöter et al. [@R07-2018-0098-0013] , who did not observe relevant differences between the vagally as well as sympathetically influenced parameters. The reason for this may be the considerable lower discrepancies (0.4 --5.2 W) and higher correlations (r=0.80--r=0.89) reported by Flöter et al. [@R07-2018-0098-0013] . The time-domain parameter HRV ~SDNN~ reflects the overall variability [@R07-2018-0098-0034] and demonstrated only weak correlations (r=0.55--r=0.59). However, HRV ~SDNN~ demonstrated the lowest discrepancy to the MLSS (−16.0 W) compared to HRVt ~SD1~ (−18.5 W) and HRVt ~SD2~ (−19.8 W). To our knowledge, only one study investigated the parameter SDNN in relation to LT. In contrast to this investigation, Karapetian et al. [@R07-2018-0098-0018] demonstrated a high correlation (r=0.82) for VO ~2~ between HRVt based on SDNN and LT in healthy adults with a wide range of aerobic capacities. Only a few studies investigated time-domain parameters in obese or overweight individuals. Quinart et al. [@R07-2018-0098-0027] reported a strong correlation (r=0.78) and a low mean difference (5.8 W) between the time-domain parameter of the root mean square of successive differences (rMSSD) and VT in obese adolescents. Vasconcellos et al. [@R07-2018-0098-0038] also demonstrated high correlations between the parameter rMSSD and VT (r=0.8--r=0.9) and a low mean difference of power (2.8 W) in adolescent boys. The parameter rMSSD represents primarily the vagal activity [@R07-2018-0098-0020] , which is strongly associated with ventilation [@R07-2018-0098-0008] [@R07-2018-0098-0010] [@R07-2018-0098-0014] [@R07-2018-0098-0015] ,50\]. This could explain the high correlations between HRVt based on rMSSD and VT in the studies of Vasconcellos et al. [@R07-2018-0098-0038] and Quinart et al. [@R07-2018-0098-0027] . Therefore, time-domain analyses seem to be useful to detect LT in healthy adults [@R07-2018-0098-0018] and to detect VT in obese persons [@R07-2018-0098-0027] [@R07-2018-0098-0038] . However, the results of this study indicated that the overall variability parameter SDNN is inadequate to identify the MLSS in obese or overweight individuals.

A comparison of group outcomes demonstrated only slight differences between OB and OW ( [Table 3](#TB07-2018-0098-0003){ref-type="table"} and [4](#TB07-2018-0098-0004){ref-type="table"} ). OB revealed a higher correlation and a lower difference for HRV ~SD1~ (r=0.76, 16.8%) compared to the OW (r=0.66, 22.4%). In contrast, OW exhibited a higher correlation and a lower difference for HRV ~SD2~ (r=0.66, 22.4%) compared to the OB (r=0.56, 22.6%). Furthermore, OB reached HRVt at lower values of %P ~max~ (69.2--72.9%) in comparison to the OW (72.5--75.6%) ( [Table 4](#TB07-2018-0098-0004){ref-type="table"} ). This could be explained by the fact that an increase of body fat is associated with a decrease of HRV [@R07-2018-0098-0033] . It should be noted that the OB revealed high values for the vagally modulated parameter HRVt ~SD1~ (r=0.76) but a considerable lower correlation for the vagally as well as sympathetically influenced parameter HRVt ~SD2~ (r=0.56) ( [Table 3](#TB07-2018-0098-0003){ref-type="table"} ). This is in contrast to Flöter et al. [@R07-2018-0098-0013] , who did not observe relevant differences between vagal-modulated and vagally as well as sympathetically influenced parameters. This indicated a higher sensitivity of the primarily vagally modulated parameters in detecting the MLSS in obese and overweight persons. HRVt ~SDNN~ demonstrated only weak correlations for both groups (r=0.56 to r=0.59). Therefore, the overall variability parameter SDNN is inadequate to identify the MLSS in obese or overweight individuals.

Limits
------

Some limitations of this study need to be considered. The detection of HRVt did not succeed for all participants. For 2 participants, HRVt could not be determined because of the insufficient quality of the ECG. The reason for this remains unclear. Possibly it might have been caused by body fat or the irregular ECG signal induced by exercise. Other studies that investigated obese participants did not report any data in this context [@R07-2018-0098-0027] [@R07-2018-0098-0030] [@R07-2018-0098-0038] . Furthermore, the relatively small sample size is a limiting factor. HRVt ~SD2~ and HRVt ~SDNN~ were determined by visual evaluation. This constitutes a methodological bias but represents the commonly used method in practice. Moreover, HRV analyses were conducted by specifically developed software. This is in contrast to recommendations for HRV analysis [@R07-2018-0098-0034] and to other studies but did make it possible to observe and process the raw data.

Conclusion
==========

The results of this study extended previous findings about HRV and LT. Moderate to strong agreements between HRVt and the MLSS in overweight and obese persons were demonstrated. Specifically, the foremost vagally modulated parameter HRVt ~SD1~ revealed a higher correlation and lower differences compared to the vagally and sympathetically influenced parameters HRVt ~SD2~ . This indicates a higher sensitivity of the foremost vagal modulated parameters to detect the MLSS in obese and overweight subjects. Moreover, HRVt were detected at higher intensities compared to the MLSS, which suggests a delayed vagal withdrawal during incremental exercise in obese and overweight persons.. In comparison with other studies, HRVt overestimated MLSS by a substantial amount. In the light of these findings, the use of HRV to determine the MLSS in obese and overweight subjects seems questionable.
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